1016 related articles for article (PubMed ID: 11120926)
21. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
22. Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).
Yamano Y; Nagai M; Brennan M; Mora CA; Soldan SS; Tomaru U; Takenouchi N; Izumo S; Osame M; Jacobson S
Blood; 2002 Jan; 99(1):88-94. PubMed ID: 11756157
[TBL] [Abstract][Full Text] [Related]
23. Blood mononuclear cells in patients with HTLV-I-associated myelopathy: lymphocytes are highly activated and adhesion to endothelial cells is increased.
Al-Fahim A; Cabre P; Kastrukoff L; Dorovini-Zis K; Oger J
Cell Immunol; 1999 Nov; 198(1):1-10. PubMed ID: 10612646
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of human T lymphotropic virus (HTLV)-I-specific T cell clones in HTLV-I-associated myelopathy/tropical spastic paraparesis patients.
Höger TA; Jacobson S; Kawanishi T; Kato T; Nishioka K; Yamamoto K
J Immunol; 1997 Aug; 159(4):2042-8. PubMed ID: 9257872
[TBL] [Abstract][Full Text] [Related]
25. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease.
Jacobson S; Shida H; McFarlin DE; Fauci AS; Koenig S
Nature; 1990 Nov; 348(6298):245-8. PubMed ID: 2146511
[TBL] [Abstract][Full Text] [Related]
26. Bronchoalveolar lymphocytosis correlates with human T lymphotropic virus type I (HTLV-I) proviral DNA load in HTLV-I carriers.
Mori S; Mizoguchi A; Kawabata M; Fukunaga H; Usuku K; Maruyama I; Osame M
Thorax; 2005 Feb; 60(2):138-43. PubMed ID: 15681503
[TBL] [Abstract][Full Text] [Related]
27. Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.
Biddison WE; Kubota R; Kawanishi T; Taub DD; Cruikshank WW; Center DM; Connor EW; Utz U; Jacobson S
J Immunol; 1997 Aug; 159(4):2018-25. PubMed ID: 9257869
[TBL] [Abstract][Full Text] [Related]
28. Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease.
Oh U; Yamano Y; Mora CA; Ohayon J; Bagnato F; Butman JA; Dambrosia J; Leist TP; McFarland H; Jacobson S
Ann Neurol; 2005 Apr; 57(4):526-34. PubMed ID: 15786444
[TBL] [Abstract][Full Text] [Related]
29. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients.
Greten TF; Slansky JE; Kubota R; Soldan SS; Jaffee EM; Leist TP; Pardoll DM; Jacobson S; Schneck JP
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7568-73. PubMed ID: 9636190
[TBL] [Abstract][Full Text] [Related]
30. IFN-gamma production in response to Tax 161-233, and frequency of CD4+ Foxp3+ and Lin HLA-DRhigh CD123+ cells, discriminate HAM/TSP patients from asymptomatic HTLV-1-carriers in a Peruvian population.
Best I; López G; Verdonck K; González E; Tipismana M; Gotuzzo E; Vanham G; Clark D
Immunology; 2009 Sep; 128(1 Suppl):e777-86. PubMed ID: 19740339
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
32. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
33. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
[TBL] [Abstract][Full Text] [Related]
34. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
Sabouri AH; Saito M; Lloyd AL; Vine AM; Witkover AW; Furukawa Y; Izumo S; Arimura K; Marshall SE; Usuku K; Bangham CR; Osame M
J Infect Dis; 2004 Oct; 190(7):1279-85. PubMed ID: 15346339
[TBL] [Abstract][Full Text] [Related]
35. Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients.
Alberti C; Cartier L; Valenzuela MA; Puente J; Tanaka Y; Ramirez E
J Med Virol; 2011 Sep; 83(9):1641-9. PubMed ID: 21739457
[TBL] [Abstract][Full Text] [Related]
36. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
Araya N; Takahashi K; Sato T; Nakamura T; Sawa C; Hasegawa D; Ando H; Aratani S; Yagishita N; Fujii R; Oka H; Nishioka K; Nakajima T; Mori N; Yamano Y
Antivir Ther; 2011; 16(1):89-98. PubMed ID: 21311112
[TBL] [Abstract][Full Text] [Related]
37. Induction of CD4+, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP. Recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1.
Jacobson S; Reuben JS; Streilein RD; Palker TJ
J Immunol; 1991 Feb; 146(4):1155-62. PubMed ID: 1704032
[TBL] [Abstract][Full Text] [Related]
38. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
39. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
Saito M; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
J Neurol Sci; 2004 Apr; 219(1-2):157-61. PubMed ID: 15050452
[TBL] [Abstract][Full Text] [Related]
40. Reduction in HTLV-I proviral load and spontaneous lymphoproliferation in HTLV-I-associated myelopathy/tropical spastic paraparesis patients treated with humanized anti-Tac.
Lehky TJ; Levin MC; Kubota R; Bamford RN; Flerlage AN; Soldan SS; Leist TP; Xavier A; White JD; Brown M; Fleisher TA; Top LE; Light S; McFarland HF; Waldmann TA; Jacobson S
Ann Neurol; 1998 Dec; 44(6):942-7. PubMed ID: 9851439
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
